Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Other Working Capital Changes (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Other Working Capital Changes for 14 consecutive years, with -$12000.0 as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes rose 90.08% to -$12000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$66000.0 through Dec 2025, up 69.72% year-over-year, with the annual reading at -$66000.0 for FY2025, 69.72% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$12000.0 at Plus Therapeutics, down from -$9000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $424000.0 in Q3 2022, with the low at -$459000.0 in Q1 2022.
  • Average Other Working Capital Changes over 5 years is -$21176.5, with a median of -$29000.0 recorded in 2023.
  • Peak annual rise in Other Working Capital Changes hit 867.74% in 2024, while the deepest fall reached 585.19% in 2024.
  • Over 5 years, Other Working Capital Changes stood at $170000.0 in 2021, then plummeted by 116.47% to -$28000.0 in 2022, then decreased by 7.14% to -$30000.0 in 2023, then tumbled by 303.33% to -$121000.0 in 2024, then skyrocketed by 90.08% to -$12000.0 in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$12000.0, -$9000.0, and $29000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.